Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 21461924)

1.

Evolution of attenuating mutations in dengue-2 strain S16803 PDK50 vaccine and comparison of growth kinetics with parent virus.

Kelly EP, Polo S, Sun W, Falgout B.

Virus Genes. 2011 Aug;43(1):18-26. doi: 10.1007/s11262-011-0602-z. Epub 2011 Apr 3.

PMID:
21461924
2.

Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate.

Kelly EP, Puri B, Sun W, Falgout B.

Vaccine. 2010 Apr 9;28(17):3030-7. doi: 10.1016/j.vaccine.2009.10.084. Epub 2009 Oct 27.

PMID:
19874927
3.

Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.

Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ.

Virology. 1997 Apr 14;230(2):300-8.

4.

Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells.

Puri B, Nelson WM, Henchal EA, Hoke CH, Eckels KH, Dubois DR, Porter KR, Hayes CG.

J Gen Virol. 1997 Sep;78 ( Pt 9):2287-91.

5.
6.

Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice.

Lee HC, Yen YT, Chen WY, Wu-Hsieh BA, Wu SC.

PLoS One. 2011;6(10):e25800. doi: 10.1371/journal.pone.0025800. Epub 2011 Oct 28.

7.
8.

Replication of the primary dog kidney-53 dengue 2 virus vaccine candidate in Aedes aegypti is modulated by a mutation in the 5' untranslated region and amino acid substitutions in nonstructural proteins 1 and 3.

Brault AC, Kinney RM, Maharaj PD, Green EN, Reisen WK, Huang CY.

Vector Borne Zoonotic Dis. 2011 Jun;11(6):683-9. doi: 10.1089/vbz.2010.0150. Epub 2011 Feb 1.

PMID:
21284523
9.

Study of biologic attributes of Cuban dengue 2 virus after serial passage in primary dog kidney cells.

Alvarez M, Guzmán MG, Pupo M, Morier L, Bravo J, Rodriguez R.

Int J Infect Dis. 2001;5(1):35-9.

10.

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Huang CY, Butrapet S, Pierro DJ, Chang GJ, Hunt AR, Bhamarapravati N, Gubler DJ, Kinney RM.

J Virol. 2000 Apr;74(7):3020-8.

11.

Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.

Mantel N, Girerd Y, Geny C, Bernard I, Pontvianne J, Lang J, Barban V.

Vaccine. 2011 Sep 2;29(38):6629-35. doi: 10.1016/j.vaccine.2011.06.101. Epub 2011 Jul 13.

PMID:
21745519
12.

Impact of dengue virus infection and its control.

Igarashi A.

FEMS Immunol Med Microbiol. 1997 Aug;18(4):291-300.

13.

Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels.

Halstead SB, Diwan AR, Marchette NJ, Palumbo NE, Srisukonth L.

Am J Trop Med Hyg. 1984 Jul;33(4):654-65.

PMID:
6476212
14.

Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells.

Halstead SB, Eckels KH, Putvatana R, Larsen LK, Marchette NJ.

Am J Trop Med Hyg. 1984 Jul;33(4):679-83.

PMID:
6476215
15.
16.
17.
18.
20.

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.

Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Eckels KH, Dubois DR, Summers PL, Hoke CH.

J Infect Dis. 1994 Dec;170(6):1448-55.

PMID:
7995984
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk